-
Updates include teplizumab to delay type 1 diabetes onset and early screening for liver disease.
-
Heart failure and chronic kidney disease are the first and most frequent manifestations of cardiovascular disease in people with type 2 diabetes and are also associated with increased morbidity...
-
First-of-its-kind data simulation tool measures the human and public health impact of type 1 diabetes in every country across the globe.
Current data reveals that over 530 million people are living with diabetes and over 850 million with chronic kidney disease, also known as CKD. In recent decades, both conditions have seen a dramatic increase in cases.
> Read more
Nanosensor technology combined with cell transplants holds enormous potential for treating type 1 diabetes. Despite the challenges, we are coming closer to changing the lives of people with the condition.
> Read more
Type 2 diabetes disproportionately affects Indigenous Populations worldwide, making the condition in these communities a global health emergency.
> Read more
Awareness, capacity-building and accurate data are key to tackling this common and serious complication affecting people with diabetes.
> Read more
Type 1 diabetes has been traditionally associated with children and young adults, but recent research indicates that the condition impacts and is on the rise in all age groups.
> Read more